Clinical Trial Details
Braintumor Website

[Information provided by:, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT03288272 : Evaluation of Repeated Whole Brain Radiotherapy Versus Best Supportive Care for Multiple Brain Metastases.
PhasePhase 2
AgesMin: 18 Years Max: N/A
Inclusion criteria:

- histologically confirmed malignancy

- previous WBRT

- MR-imaging confirmed cerebral metastases (>1)

- age = 18 years of age

- Karnofsky Performance Score ³60

- For women with childbearing potential, (and men) adequate contraception.

- Ability of subject to understand character and individual consequences of the clinical

- Written informed consent (must be available before enrolment in the trial)

Exclusion Criteria

- refusal of the patients to take part in the study

- Patients who have not yet recovered from acute high-grade toxicities of prior

- Pregnant or lactating women

- Participation in another clinical study or observation period of competing trials,
LinksPermanent Link to THIS page:      |      Link to official listing

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557